The Protective Effect of a Long-Acting and Multi-Target HM-3-Fc Fusion Protein in Rheumatoid Arthritis

Current treatment of rheumatoid arthritis (RA) is limited by relative shortage of treatment targets. HM-3 is a novel anti-RA polypeptide consisting of 18 amino acids with integrin αVβ3 and α5β1 as targets. Previous studies confirmed that HM-3 effectively inhibited the synovial angiogenesis and the i...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Ruijing, Li, Jian, Wang, Yibo, Zhang, Lihua, Ma, Xiaohui, Wang, Hongyu, Li, Wenlei, Cao, Xiaodan, Xu, Hanmei, Hu, Jialiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6163367/
https://www.ncbi.nlm.nih.gov/pubmed/30201867
http://dx.doi.org/10.3390/ijms19092683

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6163367/
https://www.ncbi.nlm.nih.gov/pubmed/30201867
http://dx.doi.org/10.3390/ijms19092683

Ejemplares similares